Title : Nonmyeloablative iodine-131 anti-B1 radioimmunotherapy as outpatient therapy.

Pub. Date : 1998 Jul

PMID : 9669400






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONCLUSION: Based on calculated and patient-specific exposure data, outpatient RIT with nonmyeloablative doses of 131I should be feasible for all patients under current NRC regulations. Iodine-131 nuclear receptor coactivator 6 Homo sapiens